Claire Cordella1,2, Bradford C Dickerson3, Megan Quimby3, Yana Yunusova4, Jordan R Green1,2. 1. Department of Communication Sciences and Disorders, MGH Institute of Health Professions, Boston, MA, USA. 2. Harvard-MIT Program in Speech and Hearing Bioscience and Technology, Harvard University, Cambridge, MA, USA. 3. MGH Frontotemporal Disorders Unit, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, USA. 4. Department of Speech-Language Pathology, University of Toronto, Toronto, Ontario, Canada.
Abstract
BACKGROUND: Primary progressive aphasia (PPA) is a neurodegenerative aphasic syndrome with three distinct clinical variants: non-fluent (nfvPPA), logopenic (lvPPA), and semantic (svPPA). Speech (non-) fluency is a key diagnostic marker used to aid identification of the clinical variants, and researchers have been actively developing diagnostic tools to assess speech fluency. Current approaches reveal coarse differences in fluency between subgroups, but often fail to clearly differentiate nfvPPA from the variably fluent lvPPA. More robust subtype differentiation may be possible with finer-grained measures of fluency. AIMS: We sought to identify the quantitative measures of speech rate-including articulation rate and pausing measures-that best differentiated PPA subtypes, specifically the non-fluent group (nfvPPA) from the more fluent groups (lvPPA, svPPA). The diagnostic accuracy of the quantitative speech rate variables was compared to that of a speech fluency impairment rating made by clinicians. METHODS AND PROCEDURES: Automatic estimates of pause and speech segment durations and rate measures were derived from connected speech samples of participants with PPA (N=38; 11 nfvPPA, 14 lvPPA, 13 svPPA) and healthy age-matched controls (N=8). Clinician ratings of fluency impairment were made using a previously validated clinician rating scale developed specifically for use in PPA. Receiver operating characteristic (ROC) analyses enabled a quantification of diagnostic accuracy. OUTCOMES AND RESULTS: Among the quantitative measures, articulation rate was the most effective for differentiating between nfvPPA and the more fluent lvPPA and svPPA groups. The diagnostic accuracy of both speech and articulation rate measures was markedly better than that of the clinician rating scale, and articulation rate was the best classifier overall. Area under the curve (AUC) values for articulation rate were good to excellent for identifying nfvPPA from both svPPA (AUC=.96) and lvPPA (AUC=.86). Cross-validation of accuracy results for articulation rate showed good generalizability outside the training dataset. CONCLUSIONS: Results provide empirical support for (1) the efficacy of quantitative assessments of speech fluency and (2) a distinct non-fluent PPA subtype characterized, at least in part, by an underlying disturbance in speech motor control. The trend toward improved classifier performance for quantitative rate measures demonstrates the potential for a more accurate and reliable approach to subtyping in the fluency domain, and suggests that articulation rate may be a useful input variable as part of a multi-dimensional clinical subtyping approach.
BACKGROUND:Primary progressive aphasia (PPA) is a neurodegenerative aphasic syndrome with three distinct clinical variants: non-fluent (nfvPPA), logopenic (lvPPA), and semantic (svPPA). Speech (non-) fluency is a key diagnostic marker used to aid identification of the clinical variants, and researchers have been actively developing diagnostic tools to assess speech fluency. Current approaches reveal coarse differences in fluency between subgroups, but often fail to clearly differentiate nfvPPA from the variably fluent lvPPA. More robust subtype differentiation may be possible with finer-grained measures of fluency. AIMS: We sought to identify the quantitative measures of speech rate-including articulation rate and pausing measures-that best differentiated PPA subtypes, specifically the non-fluent group (nfvPPA) from the more fluent groups (lvPPA, svPPA). The diagnostic accuracy of the quantitative speech rate variables was compared to that of a speech fluency impairment rating made by clinicians. METHODS AND PROCEDURES: Automatic estimates of pause and speech segment durations and rate measures were derived from connected speech samples of participants with PPA (N=38; 11 nfvPPA, 14 lvPPA, 13 svPPA) and healthy age-matched controls (N=8). Clinician ratings of fluency impairment were made using a previously validated clinician rating scale developed specifically for use in PPA. Receiver operating characteristic (ROC) analyses enabled a quantification of diagnostic accuracy. OUTCOMES AND RESULTS: Among the quantitative measures, articulation rate was the most effective for differentiating between nfvPPA and the more fluent lvPPA and svPPA groups. The diagnostic accuracy of both speech and articulation rate measures was markedly better than that of the clinician rating scale, and articulation rate was the best classifier overall. Area under the curve (AUC) values for articulation rate were good to excellent for identifying nfvPPA from both svPPA (AUC=.96) and lvPPA (AUC=.86). Cross-validation of accuracy results for articulation rate showed good generalizability outside the training dataset. CONCLUSIONS: Results provide empirical support for (1) the efficacy of quantitative assessments of speech fluency and (2) a distinct non-fluent PPA subtype characterized, at least in part, by an underlying disturbance in speech motor control. The trend toward improved classifier performance for quantitative rate measures demonstrates the potential for a more accurate and reliable approach to subtyping in the fluency domain, and suggests that articulation rate may be a useful input variable as part of a multi-dimensional clinical subtyping approach.
Authors: Jonathan D Rodgers; Kris Tjaden; Lynda Feenaughty; Bianca Weinstock-Guttman; Ralph H B Benedict Journal: J Int Neuropsychol Soc Date: 2012-10-12 Impact factor: 2.892
Authors: An-Tao Du; Norbert Schuff; Joel H Kramer; Howard J Rosen; Maria Luisa Gorno-Tempini; Katherine Rankin; Bruce L Miller; Michael W Weiner Journal: Brain Date: 2007-03-12 Impact factor: 13.501
Authors: Maria Luisa Gorno-Tempini; Nina F Dronkers; Katherine P Rankin; Jennifer M Ogar; La Phengrasamy; Howard J Rosen; Julene K Johnson; Michael W Weiner; Bruce L Miller Journal: Ann Neurol Date: 2004-03 Impact factor: 10.422
Authors: Stephen M Wilson; Jennifer M Ogar; Victor Laluz; Matthew Growdon; Jung Jang; Shenly Glenn; Bruce L Miller; Michael W Weiner; Maria Luisa Gorno-Tempini Journal: Neuroimage Date: 2009-06-06 Impact factor: 6.556
Authors: Sarah Grace Hudspeth Dalton; Christine Shultz; Maya L Henry; Argye E Hillis; Jessica D Richardson Journal: Am J Speech Lang Pathol Date: 2018-03-01 Impact factor: 2.408
Authors: Katarina L Haley; Adam Jacks; Jordan Jarrett; Taylor Ray; Kevin T Cunningham; Maria Luisa Gorno-Tempini; Maya L Henry Journal: J Speech Lang Hear Res Date: 2021-02-25 Impact factor: 2.297
Authors: Jordan R Green; Kristen M Allison; Claire Cordella; Brian D Richburg; Gary L Pattee; James D Berry; Eric A Macklin; Erik P Pioro; Richard A Smith Journal: Br J Clin Pharmacol Date: 2018-10-01 Impact factor: 4.335
Authors: Claire Cordella; Megan Quimby; Alexandra Touroutoglou; Michael Brickhouse; Bradford C Dickerson; Jordan R Green Journal: Neurology Date: 2019-04-03 Impact factor: 9.910